Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way
This article was originally published in PharmAsia News
Executive Summary
CAMBRIDGE, Mass. - Greater R&D collaboration was the theme of the day at the star-studded U.S.-India Chamber of Commerce biopharma and healthcare summit
You may also be interested in...
BioAsia 2015: Can India Move Beyond Its Low-cost Advantage?
Drug discovery partnerships in India are at the cusp of big changes. Global innovators have moved away from considering India as a low-cost destination, instead looking beyond just outsourcing clinical development projects or in-licensing compounds. They are keen to forge long-term relationships with academia and also to look at model start-ups to spur a culture of innovation.
Emerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test
Generon in Shanghai was founded by former Hutchison MediPharma employees to target a niche market between expensive import drugs and lower quality domestic products.
BIO 2012 Spotlight: Discussions On Biosimilars, EMs, Partnerships And Global R&D
During BIO 2012 in Boston last week global pharma leaders discussed many topics related to emerging markets. PharmAsia News takes a closer look.